MedTrace Logo

EuroPainClinics® Study III (Prospective Observational Study)

NCT02461654 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-01-13

No results posted yet for this study

Summary

In this prospective observational trial the effect of the Disc FX microinvasive therapy should be examined in (approximately 150) adult patients with low back pain.

Conditions

  • Disc Herniations

Interventions

OTHER

Disc FX

Disc FX is an innovative system allowing for a safe and effective approach to a damaged disc without injury to the surrounding structures. The procedure consists of three phases: during the first phase, the disc is punctured with a special needle that functions as a working channel. This needle is used to remove part of the degenerate inner tissue. Then, using a radio-frequency probe, the disc is sealed to minimize the risk of repeated herniation. In the final step, the pathological nerves in the back part of the disc are destroyed with the use of radio-frequency.

Sponsors & Collaborators

  • Europainclinics z.ú.

    lead OTHER

Principal Investigators

  • Juraj Mláka, MD PhD · R-Clinic

  • Ladislav Kočan, MD PhD · K-medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2021-05-31
Completion
2021-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02461654 on ClinicalTrials.gov